Biocon Reports Q1 FY24: Revenue Growth and Biosimilars Success.
Biocon, a prominent pharmaceutical company, released its financial results for the April-June quarter of fiscal year 2023-24 (Q1FY24) on August 10. The company's performance highlights include: Net Profit Decline: Biocon…